Skip to content

Arm training methods showed no clear difference in breathlessness in COPD

A rehabilitation trial found no significant difference in breathlessness changes between arm strength and endurance training, although strength gains and difficulty completing training differed.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Breathlessness decreased in both groups, but the trial found no statistically significant difference between the training methods. Strength training produced greater gains in biceps strength, while more participants struggled to reach its required intensity. The results describe a short rehabilitation comparison and do not establish that the methods are equivalent for every outcome or patient.

Keep in mind

The trial was open-label and conducted at a single center. The abstract does not describe longer-term outcomes, so it cannot show whether the observed pattern persisted.

THE RESULT, WITH CONTEXT

What researchers found

No statistically significant difference

Change in breathlessness

Arm strength versus endurance training after 4 weeks, measured with the London Chest Activity of Daily Living questionnaire.

Ann Phys Rehabil Med, 2025 · Original source ↓

Interpreting the comparison

The confidence interval for the breathlessness comparison did not include the trial's stated minimum important difference. That adds context to the nonsignificant result, but the abstract does not establish formal equivalence between the programs.

Strength and tolerability differed

Biceps strength increased more with strength training, but a larger share of that group found the required intensity too difficult. Arm exercise capacity, quality of life, anxiety and depression showed no significant between-group differences.

CHECK THE ORIGINAL

The original publication

Effect of different forms of upper limb muscle training on dyspnea in chronic obstructive pulmonary disease: a randomised controlled trial.

Beaumont M, Péran L, Berriet AC et al.
Ann Phys Rehabil Med · 2025

PubMed ID
40966966
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.